Clinical Capabilities IMP Diagnostics offers a comprehensive suite of diagnostic services including cytology, histology, histochemistry, immunohistochemistry, and molecular biology, indicating opportunities to upsell integrated pathology workflows or bundled testing for hospitals and clinics seeking end-to-end diagnostics.

Service Availability With extended hours from 9:00 to 20:30 on weekdays and Saturday mornings, the lab can accommodate tight clinical schedules and urgent specimen processing, making it a favorable partner for high-volume or time-sensitive healthcare providers.

Industry Engagement Active participation in major regional conferences (EUROGIN 2026, USOG-PLP 2025, IPO Porto 2024) suggests strong visibility and credibility in gynecologic oncology and women's health, presenting opening to co-hosted events, sponsored research, or collaborative training programs.

Digital & Outreach A tech stack featuring Google, LinkedIn, Meta Ads, WordPress, and HubSpot indicates成熟 digital marketing and CRM capabilities, enabling targeted outreach to hospitals, clinics, and academic centers for service expansion or pilot programs.

Growth Potential Current revenue is under $1M with a small-to-mid employee base, signaling opportunities for scalable partnerships, regional expansion, or value-based service models with larger diagnostic networks seeking specialized pathology capabilities.